These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30132364)

  • 1. Treatment of tuberculosis infection in children.
    Hatzenbuehler LA; Starke JR
    Expert Rev Anti Infect Ther; 2018 Sep; 16(9):695-708. PubMed ID: 30132364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis in childhood.
    Shingadia D
    Ther Adv Respir Dis; 2012 Jun; 6(3):161-71. PubMed ID: 22361927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Completion Rate and Safety of Tuberculosis Infection Treatment With Shorter Regimens.
    Cruz AT; Starke JR
    Pediatrics; 2018 Feb; 141(2):. PubMed ID: 29363561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-resistant tuberculosis in children in Thailand.
    Lapphra K; Sutthipong C; Foongladda S; Vanprapar N; Phongsamart W; Wittawatmongkol O; Saksawad R; Chokephaibulkit K
    Int J Tuberc Lung Dis; 2013 Oct; 17(10):1279-84. PubMed ID: 24025378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric drug-resistant tuberculosis: a global perspective: a global perspective.
    Reubenson G
    Paediatr Drugs; 2011 Dec; 13(6):349-55. PubMed ID: 21999648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
    Sharma SK; Sharma A; Kadhiravan T; Tharyan P
    Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003.
    Feja K; McNelley E; Tran CS; Burzynski J; Saiman L
    Pediatr Infect Dis J; 2008 Oct; 27(10):907-12. PubMed ID: 18756183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of treating multidrug-resistant tuberculosis.
    Resch SC; Salomon JA; Murray M; Weinstein MC
    PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of tuberculosis and multidrug resistant tuberculosis in the Middle East Region.
    Ahmad S; Mokaddas E; Al-Mutairi NM
    Expert Rev Anti Infect Ther; 2018 Sep; 16(9):709-721. PubMed ID: 30173588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of Tuberculosis.
    Dobbs TE; Webb RM
    Microbiol Spectr; 2017 Apr; 5(2):. PubMed ID: 28387179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Global Landscape of Tuberculosis Therapeutics.
    Tornheim JA; Dooley KE
    Annu Rev Med; 2019 Jan; 70():105-120. PubMed ID: 30403551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in drug-resistant tuberculosis after the implementation of the DOTS strategy in Shenzhen, China, 2000-2013.
    Zhu L; Yang YZ; Guan HY; Cheng SM; Jin YY; Tan WG; Wu QF; Liu XL; Zhao MG; Lu ZH; Jia ZW
    Int J Tuberc Lung Dis; 2017 Jul; 21(7):759-765. PubMed ID: 28633700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does directly observed therapy improve tuberculosis treatment? More evidence is needed to guide tuberculosis policy.
    McLaren ZM; Milliken AA; Meyer AJ; Sharp AR
    BMC Infect Dis; 2016 Oct; 16(1):537. PubMed ID: 27716104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood tuberculosis: treatment strategies and recent advances.
    Starke JR
    Paediatr Respir Rev; 2001 Jun; 2(2):103-12. PubMed ID: 12531056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic investigational new drugs for the treatment of tuberculosis.
    Kwon YS; Koh WJ
    Expert Opin Investig Drugs; 2016; 25(2):183-93. PubMed ID: 26576631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.